The article looks at paper versus electronic records in the context of complete data under the U.S. Food and Drug Administration's (FDA) Good Manufacturing Practice (GMP) regulations for quality control (QC) laboratories in the U.S. It considers whether complete data includes the electronic files generated from a chromatographic analysis or just the signed paper printouts. The requirements for complete data for laboratories working under the FDA GMP regulations are highlighted.
Comments on the efforts to shift from automation and online data processing technology in clinical trials and office practice in lieu of using paper. Development and innovation of electronic office machine equipments; Accessibility of data and information through electronic document management; Plight of the paperless clinical trails.
PUBLISHING, WEBSITES, PAPER, ARCHIVES, PHARMACEUTICAL industry
Abstract
The article reports that the EU Commission and EMEA have published several documents for consultation on their website. These documents revise some existing GMP requirements and also add some new ones. Titles of these papers include Concept Paper Dealing With the Need for Updated GMP Guidance Concerning Dedicated Manufacturing Facilities in the Manufacture of Certain Medicinal Products; Inspections at Manufacturers of Active substances; Public Consultation: Authorizations for Manufacturing and Import and GMP Certificates etc.
Published
2005
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.